about
Meta-analysis of early nonmotor features and risk factors for Parkinson diseaseThe Hitchhiker's guide to the rhinencephalonIs transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline resultsParkin disease: a clinicopathologic entity?Wilson's disease with myoclonus and white matter lesions.Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.Availability of olfactory bulb: experience from a British Brain Bank.Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study.Risk and learning in impulsive and nonimpulsive patients with Parkinson's diseaseEffects of age and cognition on a cross-cultural paediatric adaptation of the Sniffin' Sticks Identification TestClinical Findings and Natural History in Ten Unrelated Families with Juvenile and Adult GM1 Gangliosidosis.Olfactory impairment in familial ataxias.Punding and dyskinesias.Screening for VPS35 mutations in Parkinson's disease.Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?Postural deformities in Parkinson's disease.MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy.Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?The clinical features of pathologically confirmed vascular parkinsonism.Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study.Non-motor signs in Parkinson's disease: a review.A field guide to current advances in paediatric movement disorders.Regional differences in the severity of Lewy body pathology across the olfactory cortex.Identical twins with Leucine rich repeat kinase type 2 mutations discordant for Parkinson's disease.Chediak-Higashi syndrome with parkinsonism.Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations.The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil.The use of a color coded probability scale to interpret smell tests in suspected parkinsonism.Applying a new version of the Brazilian-Portuguese UPSIT smell test in Brazil.Nonmotor Symptoms in Patients with Spinocerebellar Ataxia Type 10.Parkinson disease: How reliable are prodromal indicators of Parkinson disease?Olfactory function in Parkinson's disease in ON versus OFF states.Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson's disease.Hyposmia in progressive supranuclear palsy.Concomitant progressive supranuclear palsy and multiple system atrophy: more than a simple twist of fate?Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor-ataxia syndrome.Olfaction in pathologically proven patients with multiple system atrophy.
P50
Q22252935-F778D5AA-FA1A-42AC-B464-680D9E6583D5Q28074638-F1920A77-3996-4716-8541-D5E1356054C2Q30454441-57BC8722-21DE-45F4-9CE7-F9FEA93C98FAQ30528874-5855F81D-C174-46CC-8B1F-BA17D4C6D548Q30564071-1654D229-2E22-4B9D-BB48-4344AA857AE8Q30594306-9302BCF5-4C0E-478C-A5FE-6808419EC513Q31043129-C6A0DC5B-82E9-4B8A-8E77-EC74B03761B2Q33371185-E1BD98B8-839C-4C1A-A4A4-A5583A330723Q33455317-35CDF022-810A-4372-B83B-BC1849994A1AQ34376763-B68BD271-7D9E-4CC8-A5C6-A7105F14DF9AQ34976392-BB70135E-3209-4ADE-B069-0C65C637F9B9Q35743822-66B6E557-57AC-48CF-A212-A2616758139CQ36090595-748A400E-7FAC-4F1D-B4AA-D436D3A43DF9Q36463617-30473267-72EE-4982-8EAB-024D3BA318C7Q36609692-AEAF9EAD-6D22-4E35-A85E-549756C6D88DQ36775809-1181A818-78BE-41A6-9194-C9E15616BCB9Q37346023-6D804BC3-85B5-49E3-BDE3-3F8DAFFD2F6BQ37868267-A013FF7F-56BC-4519-AA4D-F3EF40F538ACQ38062468-F4E3FDF6-C81D-4AF4-A46B-0DCE18053BDBQ38385278-349FEAF8-CCF5-4E5A-974F-55AB86077D67Q38401159-6D8C3183-BEAA-43DA-8A02-2022B6C0E362Q38429187-B8C8B21E-CB49-4862-935C-D7CECB21CA44Q38448936-D5085A81-822A-44EA-AB71-F6D26C363FFDQ38537717-1246F22F-2D79-462F-B2F9-81F8CEC85436Q39988809-CA990DDA-B34A-4C9D-87D9-64E1A7E9DC03Q41058311-6128480A-36D0-45C0-8C19-511CAC8AB6EBQ42459988-3EFAA9C7-5D9F-4070-8046-D5C62267D3F6Q42917168-E696286F-7A07-472C-82CE-54F4A0C81BD8Q43821782-24B80396-DB6E-4DB0-AD96-509D826BBCBFQ45924897-D8CC2904-0320-4AC9-B1CC-36B1C4666EEBQ46049265-2E243F64-E52A-4703-A9F4-4F8B2444C402Q47346624-8F95C6CD-FD7F-496F-AC12-203961504C39Q47723247-B12BA57A-31FC-4099-B9D1-98C9FAED86A6Q48007729-4EE379FD-D674-418D-B3A4-0DDEE8F84FB8Q48165829-187474F4-A7FB-483E-BE3B-FAC039E04093Q48190381-F12FE0A9-4390-4E69-9C06-83B83AC16847Q48281091-AA9139D0-9CF1-42B6-9131-B647A6CA9220Q48431776-D2C86793-5CB3-4EBB-B811-527D4B9644B9Q48717215-3DA0DBED-B08F-402D-A588-6A55497CAF43Q48875392-C8E982D7-C50F-4AF3-88B2-09A72BE839EE
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2184-626X
@en
name
L Silveira-Moriyama
@ast
L Silveira-Moriyama
@nl
Laura Silveira Moriyama
@en
Laura Silveira Moriyama
@es
type
label
L Silveira-Moriyama
@ast
L Silveira-Moriyama
@nl
Laura Silveira Moriyama
@en
Laura Silveira Moriyama
@es
altLabel
L Silveira Moriyama
@en
L Silveira-Moriyama
@en
L. Silveira Moriyama
@en
L. Silveira-Moriyama
@en
Laura Silveira-Moriyama
@en
Silveira Moriyama L
@en
Silveira Moriyama L.
@en
Silveira-Moriyama L
@en
Silveira-Moriyama L.
@en
prefLabel
L Silveira-Moriyama
@ast
L Silveira-Moriyama
@nl
Laura Silveira Moriyama
@en
Laura Silveira Moriyama
@es
P106
P31
P4012
P496
0000-0003-2184-626X